Here are three things to know.
1. Organogenesis employs approximately 600 people worldwide, and its management team has more than 100 years of collective experience in the regenerative medicine industry.
2. The company acquired NuTech Medical in 2017 to enter the orthopedic and spine surgical market.
3. The company’s surgical and sports medicine offerings include:
- PuraPly Antimicrobial
- Affinity
- NuShield
- ReNu
- NuCel
More articles on biologics:
Study: Single-injection durolane hylauronic acid safe, effective treatment for knee osteoarthritis
Who are the 14 major players in the global spine biologics market?
Cerapedics i-FACTOR yields 50% fusion rate vs. 20% for allograft at 1-year follow-up — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.